IP Library Patent Application 13053992
Patent Application
App. No. 13/053,992

METHOD FOR INHIBITING ACCUMULATION OF VISCERAL FAT

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/053,992
Abstract

Disclosed is: a visceral fat accumulation inhibitor or a food or drink for inhibiting the accumulation of a visceral fat, which composes a fat globule membrane component as an active ingredient; or a agent or food or drink for promoting the increase in the blood adiponection level and/or inhibiting the decrease in the blood adiponection level, which composes a fat globule membrane component as an active ingredient. A fat globule membrane component can inhibit the accumulation of a visceral fat, and/or can promote the increase in or inhibit the decrease in the blood adiponection level.

Claims (10)

1 . A method of inhibiting visceral fat accumulation in a subject, comprising administering an effective amount of a fat globule membrane component to the subject.

2 . The method of claim 1 , wherein the fat globule membrane component is in the form of a food or drink.

3 . The method of claim 1 , wherein the fat globule membrane component is a milk fat globule membrane component.

4 . The method of claim 1 , wherein the effective amount of a fat globule membrane component is 0.1 mg to 5000 mg per day.

5 . A method of increasing blood adiponectin level and/or inhibiting a decrease in blood adiponectin level in a subject, comprising administering an effective amount of a fat globule membrane component to the subject.

6 . The method of claim 5 , wherein the fat globule membrane component is in the form of a food or drink.

7 . The method of claim 5 , wherein the fat globule membrane component is a milk fat globule membrane component.

8 . The method of claim 5 , wherein the effective amount of a fat globule membrane component is 0.1 mg to 5000 mg per day.

9 . A method of treating a metabolic syndrome in a subject, comprising administering an effective amount of a fat globule membrane component to a subject in need thereof.

10 . The method of claim 9 , wherein the metabolic syndrome is selected from the group consisting of thrombosis, insulin resistance, glucose metabolic disorder, and hypertension.

Assignments (2)
MERGER Recorded Aug 4, 2011
From: SNOW MILK BRAND CO., LTD.
To: MEGMILK SNOW BRAND CO., LTD
Reel/Frame 026698/0750 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2011
From: KAWAKAMI, HIROSHI; HIGURASHI, SATOSHI; MATSUYAMA, HIROAKI
To: SNOW BRAND MILK PRODUCTS CO., LTD.
Reel/Frame 026016/0433 →